m-PEG-NHS ester (MW 1000) can be used to modify active molecules and enhance their antigenicity and immunogenicity, which is beneficial for the preparation of injectable preparations. m-PEG-NHS ester modification of serine protease lumbrokinase (LK) does not affect its significant fibrinolytic and thrombolytic activities, showing good application prospects.